Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loops

被引:47
作者
Slupetzky, K
Shafti-Keramat, S
Lenz, P
Brandt, S
Grassauer, A
Sara, M
Kirnbauer, R
机构
[1] Univ Vienna, Sch Med, Lab Viral Oncol, Div Immunol Allergy & Infect Dis, A-1090 Vienna, Austria
[2] Univ Vienna, Sch Med, Dept Dermatol, Div Gen Dermatol, A-1090 Vienna, Austria
[3] Univ Agr Sci, Ctr Ultrastruct Res, A-1180 Vienna, Austria
[4] Univ Agr Sci, Ludwig Boltzmann Inst Mol Nanotechnol, A-1180 Vienna, Austria
基金
奥地利科学基金会;
关键词
D O I
10.1099/0022-1317-82-11-2799
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Neutralization capsid epitopes are important determinants for antibody-mediated immune protection against papillomavirus (PV) infection and induced disease. Chimeric L1 major capsid proteins of the human PV type 16 (HPV-16) and the bovine PV type 1 (BPV-1) with a foreign peptide incorporated into several capsid surface loops self-assembled into pentamers or virus-like particles (VLP). Binding patterns of neutralizing monoclonal antibodies (MAb) and immunization of mice confirmed (i) that regions around aa 282-286 and 351-355 contribute to neutralization epitopes and identified the latter region as an immunodominant site and (ii) that placing a foreign peptide in the context of an assembled structure markedly enhanced its immunogenicity. Pentamers disassembled from wild-type HPV-16 and BPV-1 VLPs displayed some of the neutralization epitopes that were detected on fully assembled VLPs, but were deficient for binding a subset of neutralizing MAb that inhibit cell attachment.
引用
收藏
页码:2799 / 2804
页数:6
相关论文
共 33 条
[1]   STRUCTURES OF BOVINE AND HUMAN PAPILLOMAVIRUSES - ANALYSIS BY CRYOELECTRON MICROSCOPY AND 3-DIMENSIONAL IMAGE-RECONSTRUCTION [J].
BAKER, TS ;
NEWCOMB, WW ;
OLSON, NH ;
COWSERT, LM ;
OLSON, C ;
BROWN, JC .
BIOPHYSICAL JOURNAL, 1991, 60 (06) :1445-1456
[2]   A FORMALIN-INACTIVATED VACCINE PROTECTS AGAINST MUCOSAL PAPILLOMAVIRUS INFECTION - A CANINE MODEL [J].
BELL, JA ;
SUNDBERG, JP ;
GHIM, SJ ;
NEWSOME, J ;
JENSON, AB ;
SCHLEGEL, R .
PATHOBIOLOGY, 1994, 62 (04) :194-198
[3]   IMMUNIZATION WITH VIRUS-LIKE PARTICLES FROM COTTONTAIL RABBIT PAPILLOMAVIRUS (CRPV) CAN PROTECT AGAINST EXPERIMENTAL CRPV INFECTION [J].
BREITBURD, F ;
KIRNBAUER, R ;
HUBBERT, NL ;
NONNENMACHER, B ;
TRINDINHDESMARQUET, C ;
ORTH, G ;
SCHILLER, JT ;
LOWY, DR .
JOURNAL OF VIROLOGY, 1995, 69 (06) :3959-3963
[4]   Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles [J].
Chackerian, B ;
Lowy, DR ;
Schiller, JT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :2373-2378
[5]   Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16 [J].
Chen, XJS ;
Garcea, RL ;
Goldberg, I ;
Casini, G ;
Harrison, SC .
MOLECULAR CELL, 2000, 5 (03) :557-567
[6]   Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus [J].
Christensen, ND ;
Reed, CA ;
Cladel, NM ;
Han, R ;
Kreider, JW .
JOURNAL OF VIROLOGY, 1996, 70 (02) :960-965
[7]   The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains [J].
Day, PM ;
Roden, RBS ;
Lowy, DR ;
Schiller, JT .
JOURNAL OF VIROLOGY, 1998, 72 (01) :142-150
[8]   A QUANTITATIVE INVITRO FOCUS ASSAY FOR BOVINE PAPILLOMA-VIRUS [J].
DVORETZKY, I ;
SHOBER, R ;
CHATTOPADHYAY, SK ;
LOWY, DR .
VIROLOGY, 1980, 103 (02) :369-375
[9]   HUMAN PAPILLOMAVIRUSES IN THE PATHOGENESIS OF ANOGENITAL CANCER [J].
HAUSEN, HZ .
VIROLOGY, 1991, 184 (01) :9-13
[10]  
HOWLEY PM, 1991, CANCER RES, V51, pS5019